Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEROS: Raxone in Leber's Hereditary Optic Neuropathy
NCT02774005Phase 4Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- May 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of idebenone in Leber hereditary optic neuropathy (LHON), sponsored by Santhera Pharmaceuticals. Started May 2016; status: completed.
02
Drugs
idebenone
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on NCT02774005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774005.